Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Entin-Meer
Characterization of Structurally Distinct, Isoform-Selective Phosphoinositide 3'-Kinase Inhibitors in Combination With Radiation in the Treatment of Glioblastoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Phosphoinositide 3-Kinase Inhibitors in Lymphoma
Current Opinion in Oncology
Cancer Research
Oncology
Characterization of GSK′963: A Structurally Distinct, Potent and Selective Inhibitor of RIP1 Kinase
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
Furan-2-Ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase G
Development of Selective Covalent Janus Kinase 3 Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Identification of IGF2 Signaling Through Phosphoinositide-3-Kinase Regulatory Subunit 3 as a Growth-Promoting Axis in Glioblastoma
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Development of an ELISA-Based HDAC Activity Assay for Characterization of Isoform-Selective Inhibitors
Journal of Biomolecular Screening
Molecular Medicine
Pharmacology
Biochemistry
Analytical Chemistry
Biotechnology
Drug Discovery
Phosphoinositide 3-Kinase-Δ (PI3Kδ); Phosphoinositide 3-Kinase Catalytic Subunit Δ-Polypeptide (PI3KCD; P110δ)
Science-Business eXchange
Targeting the Phosphoinositide 3-Kinase P110- Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
